The top ten OTCs after sales accumulated a share of more than 30% of total sales in this product segment in the fourth quarter of last year.
♦ One of ten OTC medicines, issued without a prescription, is Nurofen, produced by the British from Reckitt Benckiser ♦ It is the best-selling OTC product on the local market ♦ In second place in the top is a Romanian brand, Aspenter, produced by Terapia Cluj.
Sales of over-the-counter medicines in the last three months of 2025 show the impact of the cold season on patients, with most of the top-selling brands treating colds and flu, market research shows. The best-selling OTC drug in the fourth quarter of last year was Nurofen, produced by Reckitt Benckiser, a UK company. The market share of this brand was 11% in the mentioned period, that is, it had sales of around 23 million euros in the last quarter of the year. Thus, with the products in the range that address both pain and colds and flu, Nurofen reaches annual sales of 100 million euros on the local market, according to ZF estimates. However, compared to the previous year, in the same quarter, the British brand decreased in sales by almost 15%. A box of Nurofen cold and flu of 24 tablets is close to 40 lei, double in ten years.
For other news, analyses, articles and business information in real time, follow NV on WhatsApp Channels